Published in Nucleic Acids Res on October 15, 2010
DNA methylation status predicts cell type-specific enhancer activity. EMBO J (2011) 1.98
Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA. Genome Res (2012) 1.78
DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes. Genome Biol (2013) 1.71
Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation. Mol Cell Biol (2012) 1.20
Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE). J Nutr (2015) 1.20
Epigenetic changes in pediatric solid tumors: promising new targets. Clin Cancer Res (2012) 1.03
Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer. Hum Mol Genet (2011) 1.01
Retinoic acid upregulates ret and induces chain migration and population expansion in vagal neural crest cells to colonise the embryonic gut. PLoS One (2013) 0.90
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma. Cancer Res (2012) 0.88
Targeted DNA methylation by homology-directed repair in mammalian cells. Transcription reshapes methylation on the repaired gene. Nucleic Acids Res (2013) 0.86
A barrier-only boundary element delimits the formation of facultative heterochromatin in Drosophila melanogaster and vertebrates. Mol Cell Biol (2011) 0.85
Changes in gene expression profiling of apoptotic genes in neuroblastoma cell lines upon retinoic acid treatment. PLoS One (2013) 0.84
Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers. BMC Med Genomics (2013) 0.83
Mechanism of retinoic acid-induced transcription: histone code, DNA oxidation and formation of chromatin loops. Nucleic Acids Res (2014) 0.81
Multiple endocrine neoplasias type 2B and RET proto-oncogene. Ital J Pediatr (2012) 0.80
A novel bidirectional interaction between endothelin-3 and retinoic acid in rat enteric nervous system precursors. PLoS One (2013) 0.78
BDNF rs6265 methylation and genotype interact on risk for schizophrenia. Epigenetics (2016) 0.78
Epigenetic modifications induced by Helicobacter pylori infection through a direct microbe-gastric epithelial cells cross-talk. Med Microbiol Immunol (2013) 0.77
Epigenetic deregulation of microRNAs in rhabdomyosarcoma and neuroblastoma and translational perspectives. Int J Mol Sci (2012) 0.76
Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance. Genome Med (2017) 0.75
Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells. Mol Neurobiol (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80
The Polycomb group protein EZH2 directly controls DNA methylation. Nature (2005) 13.67
The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev (2000) 11.65
Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell (2003) 10.42
A decade of molecular biology of retinoic acid receptors. FASEB J (1996) 9.70
DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science (2003) 8.81
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (2003) 8.48
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci U S A (2005) 8.10
Combinatorial control of gene expression by nuclear receptors and coregulators. Cell (2002) 8.01
Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science (2007) 7.41
A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science (2006) 6.71
The key to development: interpreting the histone code? Curr Opin Genet Dev (2005) 4.96
Retinoic acid synthesis and signaling during early organogenesis. Cell (2008) 4.52
Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol (2006) 3.39
Role of the polycomb repressive complex 2 in acute promyelocytic leukemia. Cancer Cell (2007) 3.16
DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science (2008) 3.09
Silencing by plant Polycomb-group genes requires dispersed trimethylation of histone H3 at lysine 27. EMBO J (2006) 2.68
International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev (2006) 2.04
Retinoid therapy of high-risk neuroblastoma. Cancer Lett (2003) 1.97
Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst (1982) 1.96
Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp Cell Res (1983) 1.53
Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation (2007) 1.48
Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. Hum Mol Genet (2003) 1.46
The roles of retinoids in vertebrate development. Annu Rev Biochem (1995) 1.44
The histone-binding code of nuclear receptor co-repressors matches the substrate specificity of histone deacetylase 3. EMBO Rep (2005) 1.28
Dynamic combinatorial networks in nuclear receptor-mediated transcription. J Biol Chem (2005) 1.27
Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Mol Cell Biol (1995) 1.20
Caught in conspiracy: cooperation between DNA methylation and histone H3K9 methylation in the establishment and maintenance of heterochromatin. Biochem Cell Biol (2005) 1.16
TACC3 mediates the association of MBD2 with histone acetyltransferases and relieves transcriptional repression of methylated promoters. Nucleic Acids Res (2006) 1.12
MBDin, a novel MBD2-interacting protein, relieves MBD2 repression potential and reactivates transcription from methylated promoters. Mol Cell Biol (2003) 1.12
A position-dependent organisation of retinoid response elements is conserved in the vertebrate Hox clusters. Trends Genet (2003) 0.98
Phosphorylation of histone H3 is functionally linked to retinoic acid receptor beta promoter activation. EMBO Rep (2002) 0.97
The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma. Mol Cancer Ther (2007) 0.95
Cell-line specific chromatin acetylation at the Sox10-Pax3 enhancer site modulates the RET proto-oncogene expression. FEBS Lett (2002) 0.91
In vivo analysis of DNA methylation patterns recognized by specific proteins: coupling CHIP and bisulfite analysis. Biotechniques (2004) 0.88
Dynamic regulation of DNA methylation coupled transcriptional repression: BDNF regulation by MeCP2. Bioessays (2004) 0.83
Comparative genomic sequence analysis coupled to chromatin immunoprecipitation: a screening procedure applied to search for regulatory elements at the RET locus. Physiol Genomics (2005) 0.77
MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer (2006) 4.11
Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus. J Cell Biol (1999) 4.00
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell (1990) 3.98
The collagen gene: evidence for its evolutinary assembly by amplification of a DNA segment containing an exon of 54 bp. Cell (1980) 3.66
Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res (1997) 3.55
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene (2007) 3.29
RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem (1997) 3.26
Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes. EMBO J (2001) 2.97
Calorimetric determination of the enthalpy change for the alpha-helix to coil transition of an alanine peptide in water. Proc Natl Acad Sci U S A (1991) 2.84
Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science (1995) 2.83
Nucleotide sequence of the attenuator region of the histidine operon of Escherichia coli K-12. Proc Natl Acad Sci U S A (1978) 2.71
International Quality of Life Assessment (IQOLA) Project. Qual Life Res (1992) 2.64
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature (1987) 2.60
The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res (1999) 2.56
Role of the small GTPase Rab7 in the late endocytic pathway. J Biol Chem (1997) 2.43
Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol (1999) 2.38
Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol (1995) 2.22
Isolation and characterization of overlapping genomic clones covering the chicken alpha 2 (type I) collagen gene. Proc Natl Acad Sci U S A (1980) 2.18
Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope (1997) 2.15
High level expression of the HMGI (Y) gene during embryonic development. Oncogene (1996) 2.13
Histidine biosynthetic pathway and genes: structure, regulation, and evolution. Microbiol Rev (1996) 2.10
Role of the high mobility group A proteins in human lipomas. Carcinogenesis (2001) 2.08
RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J (1994) 2.04
Correlation between splicing sites within an intron and their sequence complementarity with U1 RNA. Cell (1980) 2.02
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res (1998) 2.00
Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J (2001) 1.98
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene (1989) 1.94
Characterization of a carboxy-terminal BRCA1 interacting protein. Oncogene (1998) 1.94
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Oncogene (1994) 1.87
The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology (1990) 1.87
Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues. Br J Cancer (2002) 1.87
Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev (2001) 1.85
Structure and function of the Salmonella typhimurium and Escherichia coli K-12 histidine operons. J Mol Biol (1988) 1.84
Co-operative regulation of endocytosis by three Rab5 isoforms. FEBS Lett (1995) 1.79
Ribonuclease E provides substrates for ribonuclease P-dependent processing of a polycistronic mRNA. Genes Dev (1994) 1.75
The B subunit of the CAAT-binding factor NFY binds the central segment of the Co-activator p300. J Biol Chem (1999) 1.70
Biochemical and regulatory properties of Escherichia coli K-12 hisT mutants. J Bacteriol (1977) 1.69
The RET receptor: function in development and dysfunction in congenital malformation. Trends Genet (2001) 1.67
Construction of a recombinant bacterial plasmid containing pro-alpha 1(I) collagen DNA sequences. J Biol Chem (1980) 1.65
Effects of coexisting hypertension and type II diabetes mellitus on arterial stiffness. J Hum Hypertens (2004) 1.61
The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene (1995) 1.61
Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res (1989) 1.61
Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci U S A (2001) 1.60
Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding. Cancer Res (2000) 1.60
Construction of a recombinant bacterial plasmid containing a chick pro-alpha2 collagen gene sequence. Proc Natl Acad Sci U S A (1978) 1.59
A consensus motif common to all Rho-dependent prokaryotic transcription terminators. Cell (1991) 1.59
Isolation of a cDNA clone encoding rat insulin-like growth factor-II precursor. Nature (1984) 1.58
Rab5a is a common component of the apical and basolateral endocytic machinery in polarized epithelial cells. Proc Natl Acad Sci U S A (1994) 1.58
Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. Oncogene (1997) 1.57
Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene (1998) 1.52
The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene (1990) 1.52
Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J (1997) 1.51
Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infect Immun (1996) 1.51
Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc Natl Acad Sci U S A (2000) 1.47
Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc Natl Acad Sci U S A (1992) 1.46
Hypermutation in pathogenic bacteria: frequent phase variation in meningococci is a phenotypic trait of a specialized mutator biotype. Mol Cell (1999) 1.45
Dynamics of large semiflexible chains probed by fluorescence correlation spectroscopy. Phys Rev Lett (2003) 1.44
Impact of team familiarity in the operating room on surgical complications. World J Surg (2014) 1.41
Identification, nucleotide sequence and expression of the regulatory region of the histidine operon of Escherichia coli K-12. Nucleic Acids Res (1981) 1.41
Control of mRNA processing and decay in prokaryotes. Genetica (1994) 1.39
Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene (1996) 1.39
Radioisotopic assay of serum vitamin B 12 with the use of DEAE cellulose. J Lab Clin Med (1966) 1.38
Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res (1996) 1.37
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab (1999) 1.37
Structure and function of the internal promoter (hisBp) of the Escherichia coli K-12 histidine operon. J Bacteriol (1983) 1.34
In vivo and in vitro detection of the leader RNA of the histidine operon of Escherichia coli K-12. Proc Natl Acad Sci U S A (1981) 1.34
Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells. J Clin Invest (1999) 1.30
Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers. Cancer (1994) 1.30
Loss and recovery of phenotypic expression of Gross leukaemia virus. Nat New Biol (1972) 1.29
Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res (1998) 1.29
Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol Cell Biol (2001) 1.29
Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. Qual Life Res (2001) 1.29